Skip to main content
Inpatient Procedure Code

XW01397

Introduction of Satralizumab-mwge into Subcutaneous Tissue, Percutaneous Approach, New Technology Group 7

Introduce Satralizum-mwge in Subcu, Perc, New Tech 7

Axis Breakdown

Every ICD-10-PCS code is exactly seven characters, one per axis. Each character's meaning is defined by its position in the code.

PositionValueMeaning
1
SectionX

New Technology

2
Body SystemW

Anatomical Regions

3
Root Operation0

Introduction

Putting in or on a therapeutic, diagnostic, nutritional, physiological, or prophylactic substance except blood or blood products

4
Body Part1

Subcutaneous Tissue

5
Approach3

Percutaneous

6
Device / Substance / Technology9

Satralizumab-mwge

7
New Technology Group7

New Technology Group 7

Related Codes

Same operation — other Device

Same table and root operation, differing only in the device character.

XW013V7 — Introduction of COVID-19 Vaccine Dose 3 into Subcutaneous Tissue, Percutaneous Approach, New Technology Group 7, XW013W7 — Introduction of COVID-19 Vaccine Booster into Subcutaneous Tissue, Percutaneous Approach, New Technology Group 7

Contextual Map

Every relationship of XW01397 in one view: hierarchy, official tabular instructions in both directions, clinical classification, risk adjustment, MS-DRG participation, index terms and change history — each edge carrying the CMS source it derives from.

PCS table

  • XW0[PCS table]
  • [object Object] — Section: [object Object] [Section]: “[object Object]”
  • [object Object] — Body System: [object Object] [Body System]: “[object Object]”
  • [object Object] — Operation: [object Object] [Operation]: “[object Object]”

Nearest codes

  • XW013V7 — Introduction of COVID-19 Vaccine Dose 3 into Subcutaneous Tissue, Percutaneous Approach, New Technology Group 7 [One axis away]
  • XW013W7 — Introduction of COVID-19 Vaccine Booster into Subcutaneous Tissue, Percutaneous Approach, New Technology Group 7 [One axis away]

Change history

  • FY2027 — Removed from the code set [Change history]

Valid now — removed for FY2027, not valid on or after October 1, 2026

Change history

  • FY2027 — 2026-10-01
    Removed from the code set
    Introduction of Satralizumab-mwge into Subcutaneous Tissue, Percutaneous Approach, New Technology Group 7
    FY2027 changes